LURBINECTEDIN 
| LURBINECTEDIN | ATC L01XX69
ANTINEOPLASTIC TREATMENT OF METASTATIC SMALL CELL LUNG CANCER (SCLC) COVALENT ALKYLATING DRUG BINDS GUANINE RESIDUES IN THE MINOR GROOVE OF DNA FORMING ADDUCTS | INTRAVENOUS | Cmax 136.3 NANOMOLAR VD 504 LITER PPB 99 PERCENT Cl 11 LITER / HOUR HT 51 HOUR | DNA | Unknown - more at DrugCentral | ANSM (in French) Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |